Skip to main content
Watch Insiders
BBIO filings

Corporate insider profile

Hannah Valantine Filing Activity

Latest reported as Corporate insider of BridgeBio Pharma, Inc. (BBIO).

Purchase filings
0
Reported companies
2
Net open-market value
-$621,251.67
Latest transaction
Jun 23, 2026

Affiliated corporations

Reported company relationships

BBIOLatest reported

BridgeBio Pharma, Inc.

Corporate insider

CDNAPrior filing

CareDx, Inc.

Director

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 23, 2026BridgeBio Pharma, Inc. (BBIO)Corporate insiderSale5,004$68.25$341,524
Jun 15, 2026CareDx, Inc. (CDNA)DirectorSale12,103$23.11$279,728